Detailed information for compound 23814

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 290.401 | Formula: C17H26N2O2
  • H donors: 1 H acceptors: 1 LogP: 2.48 Rotable bonds: 3
    Rule of 5 violations (Lipinski): 1
  • SMILES: COc1ccc(cc1)N1CCN(CC1)C1CCCCC1O
  • InChi: 1S/C17H26N2O2/c1-21-15-8-6-14(7-9-15)18-10-12-19(13-11-18)16-4-2-3-5-17(16)20/h6-9,16-17,20H,2-5,10-13H2,1H3
  • InChiKey: VIMVGICKXAZKDC-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens solute carrier family 18 (vesicular acetylcholine transporter), member 3 Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Brugia malayi vesicular acetylcholine transporter unc-17 Get druggable targets OG5_133283 All targets in OG5_133283
Schistosoma mansoni vesicular acetylcholine transporter Get druggable targets OG5_133283 All targets in OG5_133283
Loa Loa (eye worm) vesicular acetylcholine transporter unc-17 Get druggable targets OG5_133283 All targets in OG5_133283
Echinococcus granulosus vesicular acetylcholine transporter Get druggable targets OG5_133283 All targets in OG5_133283
Echinococcus multilocularis vesicular acetylcholine transporter Get druggable targets OG5_133283 All targets in OG5_133283
Schistosoma japonicum ko:K08155 MFS transporter, DHA1 family, solute carrier family 18 (vesicular, putative Get druggable targets OG5_133283 All targets in OG5_133283
Onchocerca volvulus Vesicular acetylcholine transporter homolog Get druggable targets OG5_133283 All targets in OG5_133283

By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Brugia malayi Abnormal catecholamine distribution protein 1 solute carrier family 18 (vesicular acetylcholine transporter), member 3 532 aa 504 aa 34.3 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Trichomonas vaginalis CMGC family protein kinase 0.0117 0.2892 1
Schistosoma mansoni vesicular acetylcholine transporter 0.0267 0.6818 0.6736
Trypanosoma cruzi mitogen activated protein kinase 4, putative 0.0117 0.2892 1
Echinococcus granulosus mitogen activated protein kinase 0.0117 0.2892 0.2892
Echinococcus multilocularis mitogen activated protein kinase 0.0117 0.2892 0.2709
Echinococcus granulosus mitogen activated protein kinase 3 0.0117 0.2892 0.2892
Echinococcus granulosus receptor type tyrosine protein phosphatase zeta 0.0016 0.0252 0.0252
Echinococcus granulosus tyrosine protein phosphatase non receptor type 0.0389 1 1
Echinococcus granulosus receptor type tyrosine protein phosphatase 0.0016 0.0252 0.0252
Echinococcus granulosus receptor type tyrosine protein phosphatase 0.0016 0.0252 0.0252
Trypanosoma cruzi mitogen-activated protein kinase 11, putative 0.0117 0.2892 1
Echinococcus granulosus vesicular acetylcholine transporter 0.0267 0.6818 0.6818
Loa Loa (eye worm) CMGC/MAPK/ERK1 protein kinase 0.0117 0.2892 0.2709
Echinococcus multilocularis tyrosine protein phosphatase non receptor type 0.0139 0.3456 0.3288
Echinococcus granulosus Receptor type tyrosine protein phosphatase O 0.0016 0.0252 0.0252
Schistosoma mansoni protein tyrosine phosphatase n11 (shp2) 0.0139 0.3456 0.3288
Trichomonas vaginalis CMGC family protein kinase 0.0117 0.2892 1
Toxoplasma gondii CMGC kinase, MAPK family (ERK) MAPK-1 0.0117 0.2892 0.5
Loa Loa (eye worm) vesicular acetylcholine transporter unc-17 0.0267 0.6818 0.6736
Echinococcus multilocularis mitogen activated protein kinase 3 0.0117 0.2892 0.2709
Leishmania major mitogen activated protein kinase, putative,map kinase, putative 0.0117 0.2892 1
Schistosoma mansoni protein tyrosine phosphatase non-receptor type nt1 0.0389 1 1
Echinococcus granulosus protein tyrosine phosphatase n9 0.0016 0.0252 0.0252
Brugia malayi MAP kinase sur-1 0.0117 0.2892 0.2709
Schistosoma mansoni serine/threonine protein kinase 0.0117 0.2892 0.2709
Trypanosoma brucei mitogen activated protein kinase 4, putative 0.0117 0.2892 1
Brugia malayi vesicular acetylcholine transporter unc-17 0.0267 0.6818 0.6736
Echinococcus granulosus tyrosine protein phosphatase non receptor type 0.0139 0.3456 0.3456
Echinococcus granulosus Receptor type tyrosine protein phosphatase O 0.0016 0.0252 0.0252
Echinococcus multilocularis vesicular acetylcholine transporter 0.0267 0.6818 0.6736
Echinococcus multilocularis tyrosine protein phosphatase non receptor type 0.0139 0.3456 0.3288
Echinococcus granulosus tyrosine protein phosphatase non receptor type 0.0016 0.0252 0.0252
Echinococcus granulosus receptor type tyrosine protein phosphatase 0.0016 0.0252 0.0252
Trypanosoma brucei protein kinase, putative 0.0117 0.2892 1
Echinococcus multilocularis tyrosine protein phosphatase non receptor type 0.0389 1 1
Loa Loa (eye worm) protein-tyrosine phosphatase 0.0389 1 1
Entamoeba histolytica protein tyrosine phosphatase, putative 0.0016 0.0252 1
Onchocerca volvulus Vesicular acetylcholine transporter homolog 0.0267 0.6818 1
Echinococcus granulosus tyrosine protein phosphatase non receptor type 0.0016 0.0252 0.0252
Leishmania major mitogen activated protein kinase 4, putative;with=GeneDB:LmxM19.1440 0.0117 0.2892 1
Trichomonas vaginalis CMGC family protein kinase 0.0117 0.2892 1
Echinococcus granulosus receptor type tyrosine protein phosphatase zeta 0.0016 0.0252 0.0252
Echinococcus granulosus receptor type tyrosine protein phosphatase 0.0016 0.0252 0.0252
Echinococcus granulosus tyrosine protein phosphatase non receptor type 0.0139 0.3456 0.3456
Echinococcus granulosus receptor type tyrosine protein phosphatase 0.0016 0.0252 0.0252
Trichomonas vaginalis CMGC family protein kinase 0.0117 0.2892 1
Entamoeba histolytica Pten 3-phosphoinositide phosphatase, putative 0.0016 0.0252 1
Entamoeba histolytica protein tyrosine phosphatase, putative 0.0016 0.0252 1
Echinococcus granulosus receptor type tyrosine protein phosphatase 0.0016 0.0252 0.0252
Giardia lamblia Kinase, CMGC MAPK 0.0117 0.2892 1
Trypanosoma cruzi mitogen activated protein kinase 2, putative 0.0117 0.2892 1
Trypanosoma cruzi mitogen-activated protein kinase 11, putative 0.0117 0.2892 1
Echinococcus granulosus receptor type tyrosine protein phosphatase 0.0016 0.0252 0.0252
Echinococcus granulosus tyrosine protein phosphatase non receptor type 0.0016 0.0252 0.0252
Echinococcus granulosus receptor type tyrosine protein phosphatase 0.0016 0.0252 0.0252
Brugia malayi Protein-tyrosine phosphatase containing protein 0.0139 0.3456 0.3288
Loa Loa (eye worm) protein-tyrosine phosphatase 0.0139 0.3456 0.3288

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 300 nM Inhibition of active transport of [3H]-Acetylcholine using purified Torpedo californica synaptic vesicles ChEMBL. 2724295
IC50 (binding) = 300 nM Inhibition of active transport of [3H]-Acetylcholine using purified Torpedo californica synaptic vesicles ChEMBL. 2724295

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

No external resources registered for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.